Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Katja Kološa

PhD Katja Kološa
no.: 29297 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
1.03.00  Natural sciences and mathematics  Biology   
1.08.00  Natural sciences and mathematics  Control and care of the environment   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
51.91
A''
0
A'
30.62
A1/2
30.62
CI10
75
CImax
42
h10
3
A1
0.18
A3
0
Data for the last 5 years (citations for the last 10 years) on April 24, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 6  88  71  11.83 
Scopus 7  92  75  10.71 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  National Institute of Biology  Department of Genetic Toxicology and Cancer Biology 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J4-50147  Exploring the theranostic potential of aegerolysin-based protein complexes in combating bladder cancer   2023 - 2024  PhD Kristina Sepčić  3,709 
2. J2-50047  Plasma-assisted removal of emerging genotoxic contaminants from wastewater   2023 - 2024  PhD Martina Modic  2,441 
3. J1-4395  Development of novel multifunctional metal-oxide-based nanozymes and their toxicological characterisation (NaNoZymSafe)   2022 - 2024  PhD Bojana Žegura  2,656 
4. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   2022 - 2024  PhD Andrej Perdih  2,608 
5. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,050 
6. J1-3019  Computational and experimental investigation of senescent cells modulation as a new tool to combat age-related diseases   2021 - 2024  PhD Jure Borišek  1,690 
7. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   2021 - 2024    4,833 
8. J1-2465  Advanced 3D cell models: Bridging the gap between in vitro and in vivo experimental systems (hep3DGenTox)   2020 - 2023  PhD Bojana Žegura  3,177 
9. J3-2526  Unravelling glioma stem cell niches for novel therapeutic targets in glioblastoma patients   2020 - 2021  PhD Cornelis J.F. van Noorden  2,318 
10. J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi   2017 - 2020  PhD Metka Filipič  3,736 
11. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2014 - 2017  PhD Metka Filipič  4,044 
12. J1-4247  Dual nature of stem cells in cancer and their application in therapy   2011 - 2014  PhD Tamara Lah Turnšek  5,179 
13. L3-4328  Hipoksična neaktivnost: implikacije za odpoved srca, pljučno insuficienco in prekomerno težo (Slovene)   2011 - 2014  PhD Igor Mekjavić  5,774 
14. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,848 
15. J1-2095  Apoptoza tumorskih celic kot tarča kemoterapevtikov (Slovene)   2010 - 2012  PhD Tamara Lah Turnšek  1,813 
16. J1-0848  Anticarcinogenic activity of bioactive compounds from cyanobacterial source in the progression of brain tumours - glioblastoma.   2009 - 2011  PhD Tamara Lah Turnšek  2,765 
17. L1-0055  Use of mesenchymal stem cells to target gliomas: Risk assessment and evaluation of umbilical cord blood-derived mesenchymal stem cells as new cellular vectors for therapy.   2009 - 2011  PhD Irena Zajc  2,050 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   2019 - 2024  PhD Bojana Žegura  2,795 
2. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   2015 - 2017  PhD Tamara Lah Turnšek  3,125 
3. P1-0245  Ekotoksiologija, toksikološka genomika in karcinogeneza (Slovene)   2009 - 2014  PhD Tamara Lah Turnšek  3,137 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite